Characteristics | |
---|---|
 Mean age [median] (years) | 32.9 ± 3.5 [33.0] |
 Married/with partner; n (%) | 28 (74) |
 Childless; n (%) | 25 (66) |
 Overweight / Obese; n (%) | 9 (24) |
 Former/current smokers; n (%) | 11 (29) |
 Fertility preservation; n (%) | |
 No | 9 (24) |
 Yes | 29 (76) |
 Embryo CP | 2 |
 Oocyte CP | 25 |
 Ovarian tissue CP | 2 |
 GnRH agonist | 2 |
Tumour biology; n (%) | |
 HR-positive | 15 (39) |
 HER2-positive | 5 (13) |
 Triple negative | 9 (24) |
 Triple positive | 9 (24) |
Type of systemic treatments; n (%) | |
 CT only | 8 (21) |
 CT + HT | 16 (42) |
 CT + TT | 5 (13) |
 CT + TT + HT | 9 (24) |
CT type; n (%) | Â |
 Neoadjuvant | 21 (55) |
 Adjuvant | 17 (45) |
Type of CT regimen; n (%) | |
 Anthracycline-based (FEC/AC/EC) + sequential Paclitaxel/Docetaxel | 32 (84) |
 Taxane-based | 6 (16) |
Type of HT; n (%) (n = 25) | |
 Tamoxifen only | 7 (28) |
 Tamoxifen + GnRHa | 10 (40) |
 Aromatase inhibitor only | 1 (4) |
 Aromatase inhibitor + GnRHa | 5 (20) |
 GnRHa only | 2 (8) |